• 韩凌飞

    药物分析系 助理研究员(自然科学)
    领域:药物或靶标分子的在线/原位分析新方法与新技术
    联系电话:
    电子邮箱:hanlingfei@cpu.edu.cn
    办公室:
    实验室:江宁校区学院实验楼104
  • 1、教育经历
    (1) 2016/09-2021/06,我校,3499cc拉斯维加斯入口,博士
    (3) 2012/09-2016/06,我校,3499cc拉斯维加斯入口,学士
    2、工作经历
    (1) 2021/07 至今,我校,3499cc拉斯维加斯入口,博士后
    3、学术荣誉
    2022/05,江苏省卓越博士后计划
    (1) 基于SERS技术构建一体化传感体系
    (2) 体内药物或靶标分子的高效富集、原位可视化分析
    1、科研项目
    (1)江苏省科技厅, 江苏省科技计划青年基金项目,靶向基因损伤效应分子的通用型细胞传感模型评价药物杂质的基因毒性,2022-06 至 2025-06,20万元,在研,主持
    1. Huang, X, Han, L, Wang, R, Zhu, W, Zhang, N, Qu, W, Liu, W, Liu, F, Feng, F, Xue, J, Dual-Responsive Nanosystem Based On TGF-beta Blockade and Immunogenic Chemotherapy for Effective Chemoimmunotherapy. DRUG DELIV 2022, 29 (1), 1358-1369. (IF=6.419)
    2. Han L, Wang Y, Huang X, Liu F, Ma C, Feng F, Zhang J, Liu W, Qu W, Pang H, Xue J. Specific-oxygen-supply functionalized core-shell nanoparticles for smart mutual-promotion between photodynamic therapy and gambogic acid-induced chemotherapy. Biomaterials, 2020, 257: 120228.(IF=12.479)
    3. Han L, Wang Y, Huang X, Liu B, Hu L, Ma C, Liu J, Xue J, Qu W, Liu F, Feng F, Liu W. A stage-specific cancer chemotherapy strategy through flexible combination of reduction-activated charge-conversional core-shell nanoparticles. Theranostics, 2019, 9(22): 6532-6549.(IF=11.556)
    4. Han L, Hu L, Liu F, Wang X, Huang X, Liu B, Feng F, Liu W, Qu W. Redox-sensitive micelles for targeted intracellular delivery and combination chemotherapy of paclitaxel and all-trans-retinoid acid. Asian Journal of Pharmaceutical Sciences, 2019, 14(5): 531-542.(IF=6.598)
    5. Han, L, Hou, D, Ma, C, Fu, N, Liu, J, Feng, F, Liu, W, Zheng, F, Simultaneous Determination of Eight Short-Chain Aliphatic Amines in Drug Substances by HPLC with Diode Array Detection After Derivatization with Halonitrobenzenes. J SEP SCI 2017, 40 (15), 3074-3085. (IF=3.654)
    Baidu
    sogou